{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:42:50Z","timestamp":1761100970779},"reference-count":29,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":4178,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1093\/annonc\/mdn044","type":"journal-article","created":{"date-parts":[[2008,3,16]],"date-time":"2008-03-16T00:14:39Z","timestamp":1205626479000},"page":"1331-1335","source":"Crossref","is-referenced-by-count":36,"title":["Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma"],"prefix":"10.1016","volume":"19","author":[{"given":"L.","family":"Arcaini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Montanari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.P.","family":"Alessandrino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Brusamolino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Gargantini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Cairoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Bernasconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Passamonti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bonfichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Zoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bottelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Calatroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Troletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Merli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Pascutto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Majolino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Morra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lazzarino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdn044_bb0010","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1182\/blood.V100.4.1141.h81602001141_1141_1152","article-title":"Intensive therapies in follicular non-Hodgkin lymphomas","volume":"100","author":"Hunault-Berger","year":"2002","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdn044_bb0015","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1200\/JCO.2006.09.8327","article-title":"Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up","volume":"25","author":"Rohatiner","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdn044_bb0020","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1200\/JCO.2003.10.023","article-title":"High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial","volume":"21","author":"Schouten","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdn044_bb0025","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1182\/blood.V81.12.3449.3449","article-title":"Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma","volume":"8","author":"Gribben","year":"1993","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdn044_bb0030","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1182\/blood.V94.10.3325.422k13_3325_3333","article-title":"Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphomas","volume":"94","author":"Freedman","year":"1999","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdn044_bb0035","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1200\/JCO.2004.10.054","article-title":"Long-term follow-up of indolent lymphoma patients treated with high-dose sequential chemotherapy and autografting: evidence that durable molecular and clinical remission frequently can be attained only in follicular subtypes","volume":"22","author":"Corradini","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdn044_bb0040","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/sj.bmt.1701375","article-title":"Use of the polymerase chain reaction and direct sequencing analysis to detect cells with the t(14;18) in autologous bone marrow from patients with follicular lymphoma, before and after in vitro treatment","volume":"22","author":"Pappa","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdn044_bb0045","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/10428199609054834","article-title":"Comparative preclinical study of three bone marrow purging methods using PCR evaluation of residual t(14;18) lymphoma cells","volume":"23","author":"Yerly-Motta","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.1093\/annonc\/mdn044_bb0050","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/sj.bmt.1701612","article-title":"Immunomagnetic bone marrow (BM) and peripheral blood progenitor cell (PBPC) purging in follicular lymphoma (FL)","volume":"23","author":"Martin-Henao","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdn044_bb0055","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/stem.150297","article-title":"Purging peripheral blood progenitor cell grafts from lymphoma cells: quantitative comparison of immunomagnetic CD34+ selection systems","volume":"15","author":"Paulus","year":"1997","journal-title":"Stem Cells"},{"key":"10.1093\/annonc\/mdn044_bb0060","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1046\/j.1365-2141.2000.02084.x","article-title":"In vivo depletion of B cells using a combination of high-dose cytosine arabinoside\/mitoxantrone and Rituximab for autografting in patients with non-Hodgkin's lymphoma","volume":"109","author":"Voso","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1093\/annonc\/mdn044_bb0065","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1182\/blood.V96.3.864","article-title":"Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and Rituximab infusion","volume":"96","author":"Magni","year":"2000","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdn044_bb0070","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1365-2141.2002.03256.x","article-title":"A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma","volume":"116","author":"Lazzarino","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1093\/annonc\/mdn044_bb0075","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/annonc\/mdh090","article-title":"Efficiency of in vivo purging with rituximab followed by high-dose therapy (HDT) with autologous peripheral blood stem cell transplantation (PBSCT) in B-cell non-Hodgkin's lymphomas (NHL). A single institution study","volume":"15","author":"Belhadj","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdn044_bb0080","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/sj.bmt.1703515","article-title":"Rituximab in vivo purging is safe and effective in combination with CD34-positive selected autologous stem cell transplantation for salvage therapy in B-NHL","volume":"29","author":"Flohr","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdn044_bb0085","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/sj.bmt.1704102","article-title":"Quantitative molecular evaluation in autotransplant programs for follicular lymphoma: efficacy of in vivo purging by rituximab","volume":"32","author":"Galimberti","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 14","key":"10.1093\/annonc\/mdn044_bb0090","first-page":"115","article-title":"Stem cell function and engraftment is not affected by \u201cin vivo purging\u201d with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphoma","volume":"26:","author":"Buckstein","year":"1999","journal-title":"Semin Oncol"},{"key":"10.1093\/annonc\/mdn044_bb0095","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S1083-8791(00)70028-0","article-title":"Immunotherapy with rituximab during peripheral blood stem cell transplantation for non-Hodgkin's lymphoma","volume":"6","author":"Flinn","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1093\/annonc\/mdn044_bb0100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/sj.bmt.1704551","article-title":"A model of in vivo purging with rituximab and high-dose AraC in follicular and mantle cell lymphoma","volume":"34","author":"Arcaini","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdn044_bb0105","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1200\/JCO.1995.13.3.588","article-title":"BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma","volume":"13","author":"Mills","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdn044_bb0110","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdn044_bb0115","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdn044_bb0120","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1182\/blood.V90.10.4212","article-title":"Failure of immunologic purging in mantle cell lymphoma assessed by polymerase chain reaction detection of minimal residual disease","volume":"90","author":"Andersen","year":"1997","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdn044_bb0125","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1200\/JCO.1994.12.4.798","article-title":"Detection of cells bearing the t(14;18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma","volume":"12","author":"Johnson","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdn044_bb0130","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1182\/blood.V80.4.1083.1083","article-title":"Bone marrows of non-Hodgkin's lymphoma patients with a bcl-2 translocation can be purged of polymerase chain reaction-detectable lymphoma cells using monoclonal antibodies and immunomagnetic bead depletion","volume":"80","author":"Gribben","year":"1992","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdn044_bb0135","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1038\/sj.leu.2404346","article-title":"Prolonged survival and low incidence of late toxic sequelae in advanced follicular lymphoma treated with a TBI-free autografting program: updated results of the multicenter consecutive GITMO trial","volume":"20","author":"Ladetto","year":"2006","journal-title":"Leukemia"},{"key":"10.1093\/annonc\/mdn044_bb0140","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1200\/JCO.2000.18.3.527","article-title":"High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: long-term clinical and molecular follow-up","volume":"18","author":"Apostolidis","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdn044_bb0145","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1182\/blood-2006-05-021113","article-title":"Rituximab maintenance improves clinical outcome of relapsed\/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial","volume":"108","author":"van Oers","year":"2006","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdn044_bb0150","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1182\/blood-2003-04-1257","article-title":"Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma","volume":"103","author":"Horwitz","year":"2004","journal-title":"Blood"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419402901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419402901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/19\/7\/1331\/910021\/mdn044.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T08:43:27Z","timestamp":1624437807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419402901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0923753419402901"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdn044","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}